Our results corroborate observations by us and other groups in rodent malaria models that administration of antibodies against CTLA4 and/or PDL1 in vivo increases the proinflammatory T cell responses in murine malaria [18, 23, 24, 47]. The gene discussed is CTLA4; the disease is malaria.